How can Tiapridal (tiapride) be administered?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Administration of Tiapridal (Tiapride)

Tiapridal (tiapride) can be administered orally as tablets (typically 100 mg), or parenterally via intramuscular or intravenous routes, with dosing typically ranging from 100-300 mg per day divided into 2-3 doses depending on the indication.

Oral Administration

  • Standard dosing: 100-300 mg daily, typically divided into 2-3 doses (½ to 1 tablet, three times daily) 1
  • For elderly patients: Lower starting doses are recommended due to increased sensitivity
  • Tablets should be taken with or without food
  • Maximum daily dose should not exceed 400 mg in most cases

Parenteral Administration

  • Intramuscular (IM): Can be administered as deep IM injection
  • Intravenous (IV): Can be given as slow IV injection or diluted IV infusion
  • Parenteral administration should be used with caution due to small risk of neuroleptic malignant syndrome 2

Dosing Considerations by Patient Population

Elderly Patients

  • Reduced starting doses recommended
  • More susceptible to side effects, particularly sedation
  • Despite this concern, tiapride has shown relatively good tolerability in elderly patients with less cognitive impairment compared to benzodiazepines 3

Patients with Renal/Hepatic Impairment

  • Dose reduction recommended
  • More frequent monitoring for adverse effects

Indications and Specific Dosing

  1. Agitation and aggressiveness in elderly:

    • Typically 100-300 mg daily in divided doses
    • Well-tolerated in elderly populations with minimal cognitive effects 3
  2. Alcohol withdrawal management:

    • 300 mg daily, under medical supervision
    • Should be accompanied by adjunct therapy for hallucinosis and seizures in severe cases 2
  3. Dyskinetic disorders:

    • For dyskinetic forms of cerebral palsy in children: Mean dose of 11.4 mg/kg/day in three divided doses has shown clinical improvement 4

Pharmacological Properties

  • Selective dopamine D2 and D3 receptor antagonist 5
  • Shows preferential activity at receptors previously sensitized to dopamine
  • Lower propensity for causing catalepsy and sedation compared to typical neuroleptics 5

Monitoring and Precautions

  • Monitor for extrapyramidal symptoms, particularly with higher doses
  • Somnolence is the most common side effect (reported in approximately 17% of patients) 1
  • Unlike benzodiazepines, tiapride has minimal effects on vigilance and low potential for interaction with alcohol 2
  • Long-term use requires monitoring for potential tardive dyskinesia risk 2

Advantages Over Other Agents

  • Well-tolerated, especially in debilitated patients, alcoholics, and the elderly 1
  • Does not significantly impair cognitive function or memory 3
  • Has shown effectiveness in cases resistant to other therapies (reported 66% effectiveness in resistant headaches) 1

Tiapride's unique pharmacological profile makes it particularly useful in elderly patients where sedation and cognitive impairment are concerns, though appropriate dose adjustment and monitoring remain essential.

References

Research

[Prescribing tiapridal for headache and other painful conditions].

La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1978

Research

The preclinical pharmacologic profile of tiapride.

European psychiatry : the journal of the Association of European Psychiatrists, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.